Stock Events

Stock Events

Nextcure 

$7.82
15
-$0.02-0.26% 20:00 Today
+$0.00+0%22:52After hours

Statistics

Day High
8.2
Day Low
7.6
52W High
15.74
52W Low
1.55
Volume
60,626
Avg. Volume
2,155,466
Mkt Cap
35.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-11.29
-7.65
-4
-0.36
Expected EPS
-0.9
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-55.84MNet Income

Analyst Ratings

25.00Average Price Target
The highest estimate is 25.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXTC. It's not an investment recommendation.
Alphabet
4
GOOGL
Abbvie
4
ABBV
Ford Motor
4
F
Microsoft
3
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is involved in gene editing for cancer therapies, a direct competitor in innovative cancer treatments.
Novartis
NVS
Mkt Cap292.35B
Novartis is a large pharmaceutical company with a broad oncology portfolio, competing in the cancer treatment market.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences has a strong presence in oncology and cell therapy, making it a competitor in cancer treatment.
Merck
MRK
Mkt Cap366B
Merck & Co. is known for its cancer drug Keytruda, directly competing with Nextcure's cancer immunotherapies.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb, with its range of oncology products, competes in the cancer immunotherapy market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including oncology, competing with Nextcure in cancer treatment.

About

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
Show more...
CEO
Michael S. Richman
Employees
40
Country
United States
ISIN
US65343E2072
WKN
000A41AKJ

Listings

XNAS
US
NXTC
F
DE
2US0.F
STU
DE
2US0.STU
STU
DE
2US.STU

0 Comments

Share your thoughts

FAQ

What is Nextcure stock price today?▼
The current price of NXTC is $7.82 USD — it has decreased by -0.26% in the past 24 hours. Watch Nextcure stock price performance more closely on the chart.
What is Nextcure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Nextcure stocks are traded under the ticker NXTC.
Is Nextcure stock price growing?▼
NXTC stock has risen by +28.41% compared to the previous week, the month change is a +35.29% rise, over the last year Nextcure has showed a +58.3% increase.
What is Nextcure market cap?▼
Today Nextcure has the market capitalization of 35.79M
When is the next Nextcure earnings date?▼
Nextcure is going to release the next earnings report on October 29, 2026.
What were Nextcure earnings last quarter?▼
NXTC earnings for the last quarter are -2.8 USD per share, whereas the estimation was -1.95 USD resulting in a -43.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nextcure revenue for the last year?▼
Nextcure revenue for the last year amounts to 0 USD.
What is Nextcure net income for the last year?▼
NXTC net income for the last year is -55.84M USD.
How many employees does Nextcure have?▼
As of September 04, 2026, the company has 40 employees.
In which sector is Nextcure located?▼
Nextcure operates in the Health & Wellness sector.
When did Nextcure complete a stock split?▼
The last stock split for Nextcure was on July 14, 2025 with a ratio of 1:12.
Where is Nextcure headquartered?▼
Nextcure is headquartered in BELTSVILLE, United States.